| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|
| ||||||||||||||||||||||||||||||||
a Department of Pathology and Geriatrics Center, University of Michigan School of Medicine
b Institute of Gerontology
c Ann Arbor DVA Medical Center, Ann Arbor
Richard A. Miller, Geriatrics Center, Box 0940, University of Michigan School of Medicine, Ann Arbor, MI 48109-0940 E-mail: millerr{at}umich.edu.
Decision Editor: Edward J. Masoro, PhD
| Abstract |
|---|
|
|
|---|
ANALYSES of the effects of interventions on the aging process would be facilitated by the development of assays that provide useful surrogates to longevity as the principal endpoint of the study. At present the inference that a particular diet or pharmacological agent has indeed slowed down the aging process is typically based on data showing that the intervention extends life span, and in particular some estimate of the maximal life span, such as the mean age at death of the longest-lived decile of the population. Such life-span-based experiments are expensive and time consuming even for short-lived species such as mice and rats, and all but impossible for longer-lived species. An assay or set of assays that could distinguish, among a group of individuals in the same birth cohort, those who exhibited relatively youthful results on a wide range of age-sensitive tests would deserve to be considered as a biomarker of some (hypothetical) underlying aging process that influences multiple age-dependent traits in parallel. The very wide range of effects of aging on physiological function has convinced many authorities (1)(2) that no such underlying process is likely to exist, and indeed previous attempts to extract measures of "biological age" from catalogs of age-sensitive outcomes have been justly criticized on statistical grounds (3)(4). Nonetheless, the question as to whether a set of assays can be demonstrated to predict the outcome of a wide range of other age-sensitive tests is an empirical one, and it is important enough to deserve a detailed experimental study (5).
Assays that predict subsequent longevity of apparently healthy subjects are likely to be attractive candidates as potential biomarkers of aging, because it is difficult for an intervention to produce impressive increases in longevity without a parallel deceleration of multiple diseases that could each lead to death if allowed to proceed unimpeded. A small number of prior publications have shown evidence for correlations between age-sensitive traits, measured in adult life, and longevity in mice (6)(7)(8), but the most comprehensive of these noted that the correlations seemed to apply for some but not all of the inbred mouse stocks examined.
My own prior work in this area has used four-way cross mouse stocks, bred as the progeny of two different F1 hybrid mouse stocks (9)(10)(11). This breeding scheme produces a set of mice that are, in a genetic sense, full sibs, each genetically unique, each receiving 25% of its genetic endowment, at random, from the four inbred grandparental stocks. Preliminary data, acquired on a small sample
of four-way cross mice of the UM-HET3 variety, showed that longevity could be predicted by measures of CD4 memory (CD4M) T cells measured in peripheral blood cells in mice at 18 months of age (9). The association was of similar strength in both male and female mice, met a significance criterion of p < .0003 by multiple regression, and together with gender accounted for 18% of the variance in longevity among the mice. CD4M cells increase with age in many strains of mice, including UM-HET3 mice (12), and the data showed high levels of CD4M cells to be associated, as predicted, with relatively short life span. This initial report also showed suggestive evidence (p < .1) for correlations between longevity and other T-cell subsets that did not, however, meet traditional standards for statistical significance after adjustment for multiple comparisons.
The current report represents a follow-up study in which seven T-cell subsets were evaluated, at ages 8 and 18 months, among 559 UM-HET3 mice for which date of death was subsequently determined. The data show significant correlations between life span and four age-sensitive T-cell subsets measured at 18 months of age.
| Methods |
|---|
|
|
|---|
Age at Death
Cages were examined at least daily. Mice that appeared to be clinically ill (on the grounds of poor grooming, weight loss, visible or palpable tumor, or signs of infection) were observed twice daily except on weekends. Mice judged to be so seriously ill that survival for another week was extremely unlikely were sacrificed to allow optimal necropsy analysis. Mice in this group made up 62% of those in the mated female group, and 55% of the mice in the virgin male and virgin female groups.
Exclusion Criteria
Fighting by male mice caused serious wounding in approximately 25% of the cages; in these cases all males in the cages were culled, always prior to 12 months of age and typically much earlier. The few mice dying at ages less than 8 months were not included in the study, because they did not reach the age at which the first immune assessment was conducted. The study population thus included 292 mated female mice, of which 267 survived to be reexamined at 18 months; 146 virgin females, of which 136 were reexamined at 18 months; and 121 virgin males, of which 91 were tested at 18 months of age.
Assessment of T-Cell Subset Levels in Peripheral Blood
Two-color flow cytometry analyses were conducted as previously described (9) on samples of peripheral venous blood obtained at 8 and then again at 18 months of age. Table 1 shows the definition of the seven T-cell subsets that form the subject of this report.
|
| Results |
|---|
|
|
|---|
|
|
An analysis of covariance (ANCOVA) provides a more powerful statistical test for associations between T-cell subsets and longevity, by controlling for possible effects of group variables (gender, reproductive history) and for any interactions between group variables and the immune subset of interest. Table 4 shows all significant results from a set of analyses of covariance. Among these tests, only CD4P (at 18 months) showed a significant interaction for the grouping variable. Five of the T-cell subsets exhibit a significant ability to predict longevity when tested at 18 months of age; the strongest associations are for CD4M cells
and CD4P cells
. CD8M cells measured at 18 months showed a marginal association at
. I take this last finding as suggestive rather than definitive, because it emerged from a consideration of seven subsets, and application of the Bonferroni correction would require a significance level of
(i.e., .05/7, the number of tests considered).
|
, which is not significant when compared to the Bonferroni adjusted threshold of
). Although the ANCOVA analysis did not show a significant effect of group in the CD8M analysis at 8 months, a separate calculation in which mated females were contrasted to virgin females for CD8M showed a significant interaction term
as well as a significant effect for CD8M levels
, consistent with the data in Table 3 showing a much stronger correlation between CD8M and longevity in mated females than in virgin females. The univariate correlation
for CD8M levels versus longevity in mated female mice is also suggestive, but not definitive.
Fig. 1 presents scatterplots for the four T-cell subsets that have the strongest associations with life span when measured on 18-month-old mice. Single regression lines are shown for CD4, CD4M, and CD4V, for which the ANCOVA did not indicate a significant difference among the groups. For the CD4P scatterplot, the graph shows separate regression lines for each group, with the steepest slope corresponding to the virgin male group. Fig. 2 shows the scatterplot for CD8M cells, measured at 8 months of age, against longevity, with the steepest regression line corresponding to the data for the mated female animals. The strongest association, that is, for CD4P measured in virgin males at 18 months, corresponds to an increase in longevity of
60 days, that is, 7% of the mean life span, for every 10 percentage point decrease in the CD4P level. It is clear from these scatterplots, as well as from Table 3 , that variation among mice in T-cell subsets accounts for only a small, though significant, proportion of the variance among mice in longevity.
|
|
. For 18-month-old mice the calculations indicated significant regression equations for all three groups of mice, but with different optimal combinations of predictor variables.
|
ability of cluster to predict longevity; the effect of group was marginal
, and there was no evidence for an interaction term
. The right panel of Fig. 3 presents life-span values for all mice and for the three groups considered individually. The mean longevity of mice in Cluster 1 (784 days; 95% confidence limits, 763806) is significantly lower than that of mice in Cluster 2 (834 days; 95% confidence limits, 815850), and a similar disparity is seen in each of the three groups differing in gender and reproductive history. Three cluster solutions defined by using data from 18-month-old mice did not provide additional insights, nor did two- or three-cluster solutions using data from 8-month-old animals.
|
| Discussion |
|---|
|
|
|---|
, and the three strongest associations are highly significant at p < .0002. Univariate correlations (Table 3 ) calculated separately for each of the three groups suggest that the ability of individual subset markers to predict longevity may vary somewhat with gender and after mating, but only the CD4P subset exhibited a significant interaction effect, as it was strongly associated with longevity only in male animals. Subsets measured when the mice were 8 months of age are unable to predict longevity in virgin males or females, but there is suggestive evidence that high levels of CD8M cells predict short life span in mated females (p = .006 in this subset by linear regression.) It is noteworthy that for each of the associations, short life span is associated with a T-cell subset level characteristic of relatively old animals. Thus aging, in these UM-HET3 mice as in nearly all mouse stocks previously examined (12)(13)(14), tends to increase CD4M, CD8M, and CD4P proportions, and to decrease CD4 and CD4V cell levels. The correlations documented in this study are thus all in an age-consistent direction, with the "older" subset values associated with early mortality. The stepwise linear regression calculations illustrated in Table 5 show that the three groups of mice differ somewhat in which sets of T-cell subsets are optimal predictors of longevity, but because these are themselves strongly correlated by the time the mice are 18 months of age (Table 2 ), the optimal set of predictors is only slightly more efficient than other sets of the independent variables when examined by best-subset regression methods (not shown).
These associations, though statistically significant, are relatively weak: no correlation in Table 3 exceeds
, and the scatterplots (Fig. 1 and Fig. 2) illustrate the wide ranges of life span among mice with equivalent T-cell subset values. Age at death is likely to reflect the combined influence of many genetic, environmental, and stochastic factors, and conversely patterns of immune system change are likely to be responsive to a variety of influences, not all of them connected to immune aging or late-life pathology. Thus I do not find surprising the absence of a perfect correspondence between T-cell subset levels and longevity, but I believe that my present evidence argues strongly for some form of physiological linkage between immunity and longevity.
What is the basis for these associations? Consider three classes of hypothesis that differ in their directions of causality. The least interesting of these explanations involves the notion that illness, clinical or preclinical, leads both to early death and to altered subset proportions. This seems distinctly unlikely for several reasons, including the long delay between subset determination and death (mean of
8 months even for the subsets tested when the mice were 18 months of age), because of the wide range of causes of death in this heterogeneous population (9), and because the pattern of subset changes associated with diminished survival is precisely that which would be expected in accelerated aging.
Another class of models supposes that diminished immune function, as monitored by alterations in T-cell subset proportions, might in itself lead to relatively early illness and death. The third variety postulates that mice age at different rates, and that those mice in which aging is particularly rapid exhibit both earlier death and earlier changes in age-sensitive T-cell subsets. I favor the latter of these, because it is difficult to see how altered immunity per se would predispose to multiple causes of death, and because of an extensive body of work (15) testing, and failing to confirm, immune surveillance models of cancer causation. The latter model makes the prediction that youthful levels of immune status should be associated not merely with extended survival, as in the current study, but also with relatively youthful results on many other tests of age-sensitive traits, including those (e.g., patterns of liver gene expression, or collagen cross-linking, or muscle strength) unlikely to be altered by, or to alter, immune subset distributions. My colleagues and I have some preliminary data (16) suggesting an association between high CD4M levels and relatively weak muscle strength, and we are currently examining a much broader array of age-sensitive traits in immunologically characterized four-way cross mice.
A gene mapping effort now underway has already produced strong evidence (17) for a set of genetic loci whose polymorphisms variously influence levels of CD4, CD4M, CD8M, CD4V, CD4P, and CD8P T-cell subsets in UM-HET3 mice, and higher power studies, involving larger numbers of animals, are expected to extend the current understanding of how genetic variation might contribute to interanimal differences in T-cell subset levels and in longevity. Assessment of T-cell subset levels at two ages has made it possible to document quantitative trait loci that influence age-sensitive subset levels in the first 8 months of life, and other quantitative trait loci whose effect on subsets is seen only later, that is, within the 8- to 18-month interval. My colleagues and I think that both genetic and nongenetic factors are likely to contribute to interanimal variations in both immune status and life span.
The cluster analysis suggests that the effects of aging on T-cell subsets may be modulated by a relatively small number of factors. These results, illustrated in Fig. 3, showed that when mice are sorted into two groups based solely on patterns of T-cell subset levels, the groups turn out to differ significantly in life span. There is no a priori reason to expect that clusters formed on the basis of differences in T-cell subset levels should necessarily differ in longevity, and this unexpected finding therefore suggests that the immunological differences among these mice reflects some physiological dichotomy associated in a fundamental way with differences in survival and disease risks in later life.
This finding is reminiscent of the observation that tests of T-cell function conducted in relatively healthy octogenarians can be used to divide the population into three clusters, one of which was found to have a higher 2-year survival than the other two (18). In this study, improved short-term survival was associated with better T-cell proliferation, low CD8 cells, and high CD4 cells, but the protocol did not include an assessment of memory cell levels or of T-cell P-glycoprotein expression. I do not know of any previous study, in rodents or humans, in which a cluster analysis based on midlife assessments of immune status has been used to examine associations with longevity, and indeed such an analysis would be difficult to conduct on long-lived species. My data on mice suggest, however, that longitudinal studies of human populations might benefit from the inclusion of midlife assessments of age-sensitive immune status tests as potential predictors of later trajectories of age-dependent decline in multiple physiological domains.
| Acknowledgments |
|---|
Received August 3, 2000
Accepted November 2, 2000
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
W. R. Swindell, J. M. Harper, and R. A. Miller How Long Will My Mouse Live? Machine Learning Approaches for Prediction of Mouse Life Span J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2008; 63(9): 895 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Selman, S. Lingard, A. I. Choudhury, R. L. Batterham, M. Claret, M. Clements, F. Ramadani, K. Okkenhaug, E. Schuster, E. Blanc, et al. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice FASEB J, March 1, 2008; 22(3): 807 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Garcon, D. T. Patton, J. L. Emery, E. Hirsch, R. Rottapel, T. Sasaki, and K. Okkenhaug CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer Blood, February 1, 2008; 111(3): 1464 - 1471. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nakamura and K. Miyao A Method for Identifying Biomarkers of Aging and Constructing an Index of Biological Age in Humans J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2007; 62(10): 1096 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Acuna-Castillo, E. Leiva-Salcedo, C. R. Gomez, V. Perez, M. Li, C. Torres, R. Walter, D. M. Murasko, and F. Sierra T-kininogen: a biomarker of aging in fisher 344 rats with possible implications for the immune response. J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2006; 61(7): 641 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kriete Biomarkers of Aging: Combinatorial or Systems Model? Sci. Aging Knowl. Environ., January 4, 2006; 2006(1): pe1 - pe1. [Abstract] [Full Text] |
||||
![]() |
C. Huang, C. Xiong, and K. Kornfeld Measurements of age-related changes of physiological processes that predict lifespan of Caenorhabditis elegans PNAS, May 25, 2004; 101(21): 8084 - 8089. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Rikke Early Life Predictors of Old-Age Life Expectancy Sci. Aging Knowl. Environ., May 19, 2004; 2004(20): pe21 - pe21. [Abstract] [Full Text] |
||||
![]() |
R. J. Davenport Immunity Challenge Sci. Aging Knowl. Environ., June 11, 2003; 2003(23): oa1 - 1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chicurel Dangerous Liaisons Sci. Aging Knowl. Environ., October 3, 2001; 2001(1): oa3 - 3. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Miller Biomarkers of Aging Sci. Aging Knowl. Environ., October 3, 2001; 2001(1): pe2 - 2. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||
| HOME | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|---|